Selvarajan S - Search Results

1

Sarcoma of the breast: an update on a rare entity.

Lim SZ, Ong KW, Tan BK, Selvarajan S, Tan PH. Lim SZ, et al. Among authors: selvarajan s. J Clin Pathol. 2016 May;69(5):373-81. doi: 10.1136/jclinpath-2015-203545. Epub 2016 Jan 4. J Clin Pathol. 2016. PMID: 26729013 Review.

2

The HercepTest and routine C-erbB2 immunohistochemistry in breast cancer: any difference?

Selvarajan S, Bay BH, Chng MJ, Tan PH. Selvarajan S, et al. Ann Acad Med Singap. 2004 Jul;33(4):473-6. Ann Acad Med Singap. 2004. PMID: 15329759 Free article.

3

Phyllodes tumors of the breast: the role of pathologic parameters.

Tan PH, Jayabaskar T, Chuah KL, Lee HY, Tan Y, Hilmy M, Hung H, Selvarajan S, Bay BH. Tan PH, et al. Among authors: selvarajan s. Am J Clin Pathol. 2005 Apr;123(4):529-40. doi: 10.1309/U6DV-BFM8-1MLJ-C1FN. Am J Clin Pathol. 2005. PMID: 15743740

4

Pathological diagnosis of columnar cell lesions of the breast: are there issues of reproducibility?

Tan PH, Ho BC, Selvarajan S, Yap WM, Hanby A. Tan PH, et al. Among authors: selvarajan s. J Clin Pathol. 2005 Jul;58(7):705-9. doi: 10.1136/jcp.2004.025239. J Clin Pathol. 2005. PMID: 15976336 Free PMC article.

5

p53 and c-kit (CD117) protein expression as prognostic indicators in breast phyllodes tumors: a tissue microarray study.

Tan PH, Jayabaskar T, Yip G, Tan Y, Hilmy M, Selvarajan S, Bay BH. Tan PH, et al. Among authors: selvarajan s. Mod Pathol. 2005 Dec;18(12):1527-34. doi: 10.1038/modpathol.3800488. Mod Pathol. 2005. PMID: 16258510 Free article.

6

c-erbB-2 (HER-2/neu) immunohistochemistry in invasive breast cancer: is there concordance between standard sections and tissue microarrays?

Selvarajan S, Tan SY, Sii LH, Tan PH. Selvarajan S, et al. Pathology. 2006 Aug;38(4):316-20. doi: 10.1080/00313020600820872. Pathology. 2006. PMID: 16916720

7

Over-expression of c-erbB-2 correlates with nuclear morphometry and prognosis in breast carcinoma in Asian women.

Selvarajan S, Wong KY, Khoo KS, Bay BH, Tan PH. Selvarajan S, et al. Pathology. 2006 Dec;38(6):528-33. doi: 10.1080/00313020601024060. Pathology. 2006. PMID: 17393979

8

Parafibromin expression in breast cancer: a novel marker for prognostication?

Selvarajan S, Sii LH, Lee A, Yip G, Bay BH, Tan MH, Teh BT, Tan PH. Selvarajan S, et al. J Clin Pathol. 2008 Jan;61(1):64-7. doi: 10.1136/jcp.2007.048694. Epub 2007 Apr 27. J Clin Pathol. 2008. PMID: 17468290

9

Breast sarcomas and malignant phyllodes tumours: comparison of clinicopathological features, treatment strategies, prognostic factors and outcomes.

Lim SZ, Selvarajan S, Thike AA, Nasir ND, Tan BK, Ong KW, Tan PH. Lim SZ, et al. Among authors: selvarajan s. Breast Cancer Res Treat. 2016 Sep;159(2):229-44. doi: 10.1007/s10549-016-3946-1. Epub 2016 Aug 19. Breast Cancer Res Treat. 2016. PMID: 27541020

10

Genomic profile of breast sarcomas: a comparison with malignant phyllodes tumours.

Lim SZ, Ng CCY, Rajasegaran V, Guan P, Selvarajan S, Thike AA, Nasir NDBM, Koh VCY, Tan BKT, Ong KW, Teh BT, Tan PH. Lim SZ, et al. Among authors: selvarajan s. Breast Cancer Res Treat. 2019 Apr;174(2):365-373. doi: 10.1007/s10549-018-5067-5. Epub 2018 Dec 3. Breast Cancer Res Treat. 2019. PMID: 30511242

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

211 results

Search Page

Filters